Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy

This publication has 25 references indexed in Scilit:

• Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer
  Annals of Surgery, 2006
• Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma
  Cancer, 2005
• Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival
  Journal of Clinical Oncology, 2005
• Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
  Cancer, 2005
• Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
  The Annals of Thoracic Surgery, 2004
• 2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
  Cancer, 2004
• A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma
  Annals of Oncology, 2004
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
  European Journal Of Cancer, 1999
• Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Lymph node mapping of esophageal cancer
  The Annals of Thoracic Surgery, 1994